PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33079733-2	2021	The histone deacetylase (HDAC) inhibitors and the synthetic cytotoxic retinoid fenretinide have achieved durable clinical responses in T-cell lymphomas as single agents, and patients who failed prior HDAC inhibitor treatment have responded to fenretinide.	Fenretinide	79-90	histone deacetylase 9	Homo sapiens	200-204	
33079733-2	2021	The histone deacetylase (HDAC) inhibitors and the synthetic cytotoxic retinoid fenretinide have achieved durable clinical responses in T-cell lymphomas as single agents, and patients who failed prior HDAC inhibitor treatment have responded to fenretinide.	Fenretinide	243-254	histone deacetylase 9	Homo sapiens	4-23	
33079733-2	2021	The histone deacetylase (HDAC) inhibitors and the synthetic cytotoxic retinoid fenretinide have achieved durable clinical responses in T-cell lymphomas as single agents, and patients who failed prior HDAC inhibitor treatment have responded to fenretinide.	Fenretinide	243-254	histone deacetylase 9	Homo sapiens	25-29	
23764045-0	2013	The histone deacetylase inhibitor SAHA acts in synergism with fenretinide and doxorubicin to control growth of rhabdoid tumor cells.	Fenretinide	62-73	histone deacetylase 9	Homo sapiens	4-23